INDAPTUS THERAPEUTICS INC (INDP) Stock Balance Sheet
NASDAQ:INDP - Nasdaq - US45339J1051 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.38M | 13.36M | 9.63M | 39.13M | 14.67M | |||
| Marketable Securities | N/A | 0.00 | 16.81M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | 1.11M | 90.00K | |||
| Other Current Assets | 248.74K | 633.16K | 810.00K | 1.26M | 210.00K | |||
| Total Current Assets | 7.63M | 14.00M | 27.24M | 40.39M | 14.97M | |||
| Non-Current Assets | ||||||||
| PPE Net | 105.66K | 173.94K | 80.00K | 170.00K | 2.21M | |||
| Other Non-Current Assets | 504.73K | 754.73K | 740.00K | 20.00K | 3.72M | |||
| Total Non-Current Assets | 610.39K | 928.67K | 820.00K | 190.00K | 5.93M | |||
| TOTAL ASSETS | 8.24M | 14.92M | 28.06M | 40.58M | 20.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.68M | 1.97M | 2.06M | 100.00K | 600.00K | |||
| Accounts Payable | 555.95K | 806.00K | 1.38M | 4.51M | 370.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 4.37M | |||
| Total Current Liabilities | 2.23M | 2.77M | 3.43M | 4.60M | 5.33M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.01K | 73.35K | 0.00 | 70.00K | 1.03M | |||
| Total Non-Current Liabilities | 4.01K | 73.35K | 0.00 | 80.00K | 1.03M | |||
| TOTAL LIABILITIES | 2.24M | 2.85M | 3.43M | 4.68M | 6.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -56.31M | -45.42M | -29.99M | -15.67M | -203.55M | |||
| Additional Paid In Capital | 62.21M | 57.41M | 54.44M | 51.49M | 217.36M | |||
| Common Shares | 101.97K | 84.01K | 80.00K | 80.00K | 730.00K | |||
| Other Shareholders' Equity | N/A | 0.00 | 100.00K | N/A | N/A | |||
| Shares Outstanding | 10.20M | 8.40M | 8.40M | 8.26M | 1.08M | |||
| Tangible Book Value per Share | 0.59 | 1.44 | 2.93 | 4.35 | 13.45 | |||
| Total Shareholders' Equity | 6.00M | 12.08M | 24.63M | 35.90M | 14.53M | |||
| TOTAL LIABILITIES AND EQUITY | 8.24M | 14.92M | 28.06M | 40.58M | 20.90M | |||
| Statistics | ||||||||
| Current Ratio | 3.42 | 5.05 | 7.94 | 8.78 | 2.81 | |||
| Return On Assets (ROA) | -180.75% | -103.35% | -51.03% | -19.00% | -67.61% | |||
| Return On Equity (ROE) | -248.09% | -127.71% | -58.14% | -21.48% | -97.25% | |||
All data in USD , ROIC based on taxRate of 0.21